PMV Pharmaceuticals, Inc (PMVP) - Market Cap to Net Income Ratio

PMV Pharmaceuticals (PMVP) relies on partnerships with insurance organizations and clinics to develop means for restoring the p53 protein. The market value dynamics of the asset on the GURU.Markets platform, where the indicator stands at -1.10, link commercial operations with the development of precision therapy and the testing of PC14586 on groups with specific mutations. Experienced management supports the project's success, efficiently managing finances and adhering to trial deadlines.

PMVP pmvpharma.com: Price to Earnings Ratio in the range 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for PMV Pharma (PMVP)

- market price and analyst price targets:

Market Price pmvpharma.com|PMVP - Analyst Consensus Forecast

- market capitalization indicators:

Market Capitalization PMV Pharmaceuticals, Inc.|PMVP - Real Price to Acquire Entire Company

- shareholders' equity book value data:

Net Asset Value per Share PMV Pharmaceuticals|PMVP - Company Net Assets|Market Value to Book Value pmvpharma.com|PMVP - Cumulative Company Assets

- debt obligations and liquidity statistics:

- business earnings and investment ratios data:

PMVP - Net Income|Future Net Profit PMV Pharmaceuticals|PMVP - P/E Multiple|Projected Price to Earnings Ratio PMV Pharmaceuticals Inc.|PMVP - PEG Multiple|Enterprise Value to Operating Income Before Depreciation PMV Pharmaceuticals, Inc.|PMVP - Operating profit before deduction of amortization|Earnings per share for the trailing year PMV Pharmaceuticals|PMVP - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months pmvpharma.com|PMVP - Earnings growth in current year|Expected earnings per share trend next year PMV Pharmaceuticals

- issuer revenue and sales details:

PMVP - Revenue and Sales Volume|Company Expected Sales Volume pmvpharma.com|PMVP - Price-to-Revenue Ratio|Forward Price to Sales PMV Pharmaceuticals, Inc.

Comprehensive company analysis:pmvpharma.com - PMVP

The P/E ratio determines the investment payback period through the ratio of market capitalization to annual net income, reflecting the asset's degree of overvaluation. Analyzing the historical P/E of PMV Pharmaceuticals (PMVP) allows for a comparison of its current valuation against the risks of Phase 2 drug toxicity and limited liquidity, preventing an unjustifiably high premium for hypothetical commercial success.

Key competitors